Skip to content

Clinical trials

Phase 2 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2 Clear all

335 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
200211
20038
200411
200518
200614
200725
200828
200924
201016
201117
201215
201312
201418
20159
20167
20178
201810
201910
202013
20217
202213
20234
20249
20259
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed234
Terminated39
Recruiting23
Withdrawn16
Unknown status12
Not yet recruiting5
Active, not recruiting4
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China Medical University Hospital14
Yale University10
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Pfizer8
Merck Sharp & Dohme LLC7
Nathan Kline Institute for Psychiatric Research7
University of Maryland, Baltimore7
Denovo Biopharma LLC6
H. Lundbeck A/S6
AbbVie5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia335
Psychotic Disorders91
Mental Disorders26
Bipolar Disorder12
Cognitive Dysfunction12
Hallucinations8
Schizophrenia Spectrum and Other Psychotic Disorders8
Inflammation6
Obesity6
Tobacco Use Disorder6

Trials

Showing 76 to 100 of 335. Each trial links to its page on Pharma Observatory.

235 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.